INDEPENDENT THINKING. WHOLE-FOOD LIVING.NO ANIMALS / NO OIL
THENANODIET
← THE STUDY LIBRARY

Narrative review / 2009

A review outlines progress in migraine science, noting obesity, inflammation, allodynia, and medications as potential factors in migraine progression.

This narrative review summarizes advances in migraine science across clinical practice, epidemiology, and pathophysiology during the triptan era. Research demonstrated that migraine is a brain disorder originating in trigeminal neuronal pathways rather than blood vessels. Furthermore, longitudinal epidemiologic studies identified factors that determine migraine prognosis, raising questions about progression determinants such as obesity, inflammation, allodynia, and medications.

Study type
Narrative review
Who was studied
Individuals with migraine
What was measured
Migraine diagnosis, pathophysiology, prognosis, and progression mechanisms

THE PAPER

Migraine in the triptan era: lessons from epidemiology, pathophysiology, and clinical science.

Bigal ME, Ferrari M, Silberstein SD, Lipton RB, Goadsby PJ. Headache, 2009.

PubMed 19161562 ↗DOI 10.1111/j.1526-4610.2008.01336.x ↗

Weight & appetiteBrain & mood

This note is written from the study's published abstract. It summarizes what the authors reported; it is not medical advice and does not replace reading the full paper.